You are here » Home » Companies » Company Overview » Alkem Laboratories Ltd

Alkem Laboratories Ltd.

BSE: 539523 Sector: Health care
NSE: ALKEM ISIN Code: INE540L01014
BSE LIVE 15:40 | 02 Dec 1681.25 8.45
(0.51%)
OPEN

1680.00

HIGH

1712.60

LOW

1670.60

NSE LIVE 15:30 | 02 Dec 1679.70 0.60
(0.04%)
OPEN

1705.00

HIGH

1710.00

LOW

1671.00

OPEN 1680.00
PREVIOUS CLOSE 1672.80
VOLUME 3511
52-Week high 1852.95
52-Week low 1175.00
P/E 26.20
Mkt Cap.(Rs cr) 20099.34
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00
OPEN 1680.00
CLOSE 1672.80
VOLUME 3511
52-Week high 1852.95
52-Week low 1175.00
P/E 26.20
Mkt Cap.(Rs cr) 20099.34
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00

Alkem Laboratories Ltd. (ALKEM) - Chairman Speech

Company chairman speech

Dear Shareholders

It has always been my conviction that great companies are the products of strong valuesand a determination to translate those values into tangible outcomes. These iconiccompanies look beyond industry challenges market cycles and economic volatilities tobring enduring difference to society. With a great team we are building such anenterprise at Alkem.

From a very modest beginning in 1973 we have emerged as one of the dominant players inthe domestic pharmaceutical landscape; and it is heartening to note that we arereinforcing our footprint on international markets. This achievement was largely madepossible by the determination and commitment of our employees who are incessantly pushingthe levers of Alkem’s progress.

At Alkem we have created a culture of high performance with a deep commitment notjust to cure but help people lead a healthy life. This is the quintessential Alkem.

I invite you all to be a part of our journey as we brace for a lift-off.

Warm regards

Samprada Singh

Chairman Emeritus

Alkem Laboratories Limited

Executive Chairman’s Message

Dear Shareholders

At the beginning let me thank all our shareholders who have reposed faith in ourcapabilities; and I am sure that our journey ahead would be long and fruitful. Yourwhole-hearted support has made the listing of our shares on the stock exchanges aresounding success. This is a historic occasion because now we are a bigger family with amuch larger number of members whose guidance and support would be critical to elevateAlkem from a good company to a great one.

For over four decades we have consistently focused on sharpening our competitivestrengths in a rapidly evolving pharmaceutical landscape. When the landscape is changingvery fast it is critical to recalibrate strategies as we move forward and power ourgrowth engines. Our focus has always been to introduce promising products and convert theminto market-leading brands. Our emphasis is on innovation and developing the capabilitiesof our people in line with industry trends. We will continue to pursue this strategygoing forward.

We have sustained our market leadership in various therapeutic areas. We have a proventrack record of building reputable brands in India’s pharmaceutical landscape whichremains our core market. We have 50 brands and 14 brands among the top 300 brands inIndia. Having strengthened our footprint in India we have forayed into global marketsthrough both organic and inorganic strategies of growth. While the United States remainsour key focus market for international operations we have reinforced our presence in over50 countries globally.

During the financial year 2016 the Company achieved 33.3% growth in consolidatedoperating revenues accompanied with a better margin profile. exceed India’spharmaceutical market growth driven by our leading position in key therapy areas marketshare gains and new product launches. It is deeply satisfying for me to share that thisgrowth has been achieved in a rather volatile economic and industry scenario across theworld. Our people are the real heroes of Alkem who have made this stellar performancepossible.

Rapid change is a constant reality in the pharmaceutical sector globally. With changingregulatory landscape and intensifying competition it is imperative for us to learn adaptand transform at a rapid pace. We view these changes as an opportunity to raise the barfor ourselves and fine-tune our strategies for growth.

We look at last year’s achievement as a robust foundation to build the Alkem oftomorrow. Best regards

Basudeo N. Singh

Executive Chairman

Alkem Laboratories Limited

Upgrade To Premium Services

Welcome User

Business Standard is happy to inform you of the launch of "Business Standard Premium Services"

As a premium subscriber you get an across device unfettered access to a range of services which include:

  • Access Exclusive content - articles, features & opinion pieces
  • Weekly Industry/Genre specific newsletters - Choose multiple industries/genres
  • Access to 17 plus years of content archives
  • Set Stock price alerts for your portfolio and watch list and get them delivered to your e-mail box
  • End of day news alerts on 5 companies (via email)
  • NEW: Get seamless access to WSJ.com at a great price. No additional sign-up required.
 

Premium Services

In Partnership with

 

Dear Guest,

 

Welcome to the premium services of Business Standard brought to you courtesy FIS.
Kindly visit the Manage my subscription page to discover the benefits of this programme.

Enjoy Reading!
Team Business Standard